Neisseria meningitidis infection Clinical criteria orienting towards a deficiency in the proteins of the complement;Infection par Neisseria meningitidis Critères cliniques orientant vers un déficit en protéines du complément

Presse Medicale

Volumn 34, Issue 6, 2005, Pages 425-430

  Rameix Welti, M A ^a   Chedani, H ^a   Blouin, J ^a   Alonso, J M ^b   Fridman, W H ^a   Fremeaux Bacchi, Véronique ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C7; MENINGITIS VACCINE;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHILD; CLINICAL ARTICLE; COMPLEMENT CLASSICAL PATHWAY; FEMALE; HUMAN; MALE; NEISSERIA MENINGITIDIS; ONSET AGE; RETROSPECTIVE STUDY; VACCINATION;

EID: 16444376956     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)83936-3     Document Type: Article

References (25)

1. Walport MJ. Complement. First of two parts. W Engl Med 2001; 344: 1058-66.
2. Van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-66.
3. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4: 359-95.
4. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 1984; 63:243-73.
5. Kazatchkine M, Hauptmann G, Nydegger U. Techniques du complement, Inserm, Paris 1985.
6. Dragon-Durey MA, Fremeaux-Bacchi V, Blouin J, Barraud D, Fridman WH, Kazatchkine MD. Restricted genetic defects underlie human complement C6 deficiency. Clin Exp Immunol 2003; 132:87-91.
7. Hassig A. Considerations on the therapy of shock by blood transfusions, infusions of plasma and plasma substitutes in military medicine. Revint Serv Sante Armees 1964; 37: 593-8.
8. Densen P. Complement deficiencies and meningococcal disease. Clin Exp Immunol 1991; 86 Suppl 1: 57-62.
9. Zhu Z, Atkinson TP, Hovanky KT, Boppana SB, Dai YL, Densen P et al. High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA. Clin Exp Immunol 2000; 119: 305-10.
10. Zhu ZB, Totemchokchyakarn K, Atkinson TP, Volanakis JE. Molecular defects leading to human complement component C6 deficiency in an African-American family. Clin Exp Immunol 1998; 111: 91-6.
11. Wurzner R. Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit? Clin Exp Immunol 2003; 133: 156-9.
12. Kojima T, Horiuchi T, Nishizaka H, Fukumori Y, Amano T, Nagasawa K et al. Genetic basis of human complement C8 α-γ deficiency. J Immunol 1998; 161: 3762-6.
13. Saucedo L, Ackermann L, Platonov AE, Gewurz A, Rakita RM, Densen P. Delineation of additional genetic bases for C8 beta deficiency. Prevalence of null alleles and predominance of CT transition in their genesis. J Immunol 1995; 155: 5022-8.
14. Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J. Assessment of complement deficiency in patients with meningococcal disease in the Netherlands. Clin Infect Dis 1999; 28: 98-105.
15. Ellison RT, 3RD, Kohler PF, Curd JG, Judson FN, Reller LB. Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med 1983; 308: 913-16.
16. Hogasen K, Michaelsen T, Mellbye OJ, Bjune G. Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand J Immunol 1993; 37: 487-9.
17. Schlesinger M, Nave Z, Levy Y, Slater PE, Fishelson Z. Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections. Clin Exp Immunol 1990; 81: 423-7.
18. Nielsen HE, Koch C, Magnussen P, Lind I. Complement deficiencies in selected groups of patients with meningococcal disease. Scand J Infect Dis 1989; 21: 389-96.
19. Antignac A, Ducos-Galand M, Guiyoule A, Pires R, Alonso JM, Taha MK. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 2003; 37: 912-20. Epub 2003 Sep 9.
20. Fijen CA, van den Bogaard R, Schipper M, Mannens M, Schlesinger M, Nordin FG et al. Properdin deficiency: molecular basis and disease association. Mol Immunol 1999; 36: 863-7.
21. Fijen CA, Kuijper EJ, Hannema AJ, Sjoholm AG, van Putten JP. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989; 2: 585-8
22. Alonso JM, Taha MK. Les infections à méningocoques en France: les données du Centre National de Référence. MT Pédiatrie 2002; 5: 191-5.
23. Fijen CA, Kuijper B, Drogari-Apiranthitou M, van Leeuwen Y, Daha MR, Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1998; 114: 362-9.
24. Morgan BP, Orren A. Vaccination against meningococcus in complement-deficient individuals. Clin Exp Immunol 1998; 114: 327-9.
25. Potter PC, Frasch CE, van der Sande WJ, Cooper RC, Patel Y, Orren A. Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement J Infect Dis 1990; 161: 932-7.